Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome

被引:11
|
作者
Careaga, Milo [1 ,2 ,3 ]
Noyon, Tamanna [3 ]
Basuta, Kirin [4 ]
Van de Water, Judy [3 ,5 ]
Tassone, Flora [3 ,4 ]
Hagerman, Randi J. [3 ,6 ]
Ashwood, Paul [1 ,2 ,3 ]
机构
[1] Univ Calif Davis, Dept Med Microbiol & Immunol, Sacramento, CA 95817 USA
[2] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA
[4] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA USA
[5] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA USA
[6] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA
来源
JOURNAL OF NEUROINFLAMMATION | 2014年 / 11卷
关键词
Fragile x syndrome; Immune; Cytokine; Metabotropic glutamate receptor; MOUSE MODEL; EXPANDED ALLELES; GENE FMR-1; CGG REPEAT; ACTIVATION; MGLUR5; IDENTIFICATION; INFLAMMATION; PERFORMANCE; PROFILES;
D O I
10.1186/1742-2094-11-110
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Fragile X syndrome (FXS) is the leading cause of inheritable intellectual disability in male children, and is predominantly caused by a single gene mutation resulting in expanded trinucleotide CGG-repeats within the 5' untranslated region of the fragile X mental retardation (FMR1) gene. Reports have suggested the presence of immune dysregulation in FXS with evidence of altered plasma cytokine levels; however, no studies have directly assessed functional cellular immune responses in children with FXS. In order to ascertain if immune dysregulation is present in children with FXS, dynamic cellular responses to immune stimulation were examined. Methods: Peripheral blood mononuclear cells (PBMC) were from male children with FXS (n = 27) and from male aged-matched typically developing (TD) controls (n = 8). PBMC were cultured for 48 hours in media alone or with lipopolysaccharides (LPS; 1 mu g/mL) to stimulate the innate immune response or with phytohemagglutinin (PHA; 8 mu g/mL) to stimulate the adaptive T-cell response. Additionally, the group I mGluR agonist, DHPG, was added to cultures to ascertain the role of mGluR signaling in the immune response in subject with FXS. Supernatants were harvested and cytokine levels were assessed using Luminex multiplexing technology. Results: Children with FXS displayed similar innate immune response following challenge with LPS alone when compared with TD controls; however, when LPS was added in the presence of a group I mGluR agonist, DHPG, increased immune response were observed in children with FXS for a number of pro-inflammatory cytokines including IL-6 (P = 0.02), and IL-12p40 (P < 0.01). Following PHA stimulation, with or without DHPG, no significant differences between subjects with FXS and TD were seen. Conclusions: In unstimulated cultures, subjects with FXS did not display altered dynamic immune response to LPS or PHA alone; however, subjects with FXS showed an altered response to co-current stimulation of LPS and DHPG, such that subjects with FXS failed to inhibit production of pro-inflammatory cytokines, suggesting a role of group I mGluR signaling in innate immune responses in FXS.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Mechanisms and functional impact of Group I metabotropic glutamate receptor modulation of excitability in mouse MNTB neurons
    dos Santos e Alhadas, Everton
    Bernal Correa, Ana Maria
    Naves, Ligia Araujo
    Kushmerick, Christopher
    SYNAPSE, 2020, 74 (03)
  • [32] β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X
    Stoppel, Laura J.
    Auerbach, Benjamin D.
    Senter, Rebecca K.
    Preza, Anthony R.
    Lefkowitz, Robert J.
    Bear, Mark F.
    CELL REPORTS, 2017, 18 (12): : 2807 - 2814
  • [33] Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at Synapses in a mouse model of fragile X syndrome
    Muddashetty, Ravi S.
    Kelic, Sofija
    Gross, Christina
    Xu, Mei
    Bassell, Gary J.
    JOURNAL OF NEUROSCIENCE, 2007, 27 (20) : 5338 - 5348
  • [34] Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction
    Olive, M. Foster
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 639 (1-3) : 47 - 58
  • [35] The mechanism of presynaptic long-term depression mediated by group I metabotropic glutamate receptors
    Tan, YS
    Hori, N
    Carpenter, DO
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2003, 23 (02) : 187 - 203
  • [36] Metabotropic Glutamate Receptor-Mediated Use-Dependent Down-Regulation of Synaptic Excitability Involves the Fragile X Mental Retardation Protein
    Repicky, Sarah
    Broadie, Kendal
    JOURNAL OF NEUROPHYSIOLOGY, 2009, 101 (02) : 672 - 687
  • [37] Excitation of rat subthalamic nucleus neurones in vitro by activation of a group I metabotropic glutamate receptor
    Abbott, A
    Wigmore, MA
    Lacey, MG
    BRAIN RESEARCH, 1997, 766 (1-2) : 162 - 167
  • [38] Metabotropic Glutamate Receptor 5 Upregulation in Children with Autism is Associated with Underexpression of Both Fragile X Mental Retardation Protein and GABAA Receptor Beta 3 in Adults with Autism
    Fatemi, S. Hossein
    Folsom, Timothy D.
    Kneeland, Rachel E.
    Liesch, Stephanie B.
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2011, 294 (10): : 1635 - 1645
  • [39] Group I metabotropic glutamate receptor-dependent TRPC channel trafficking in hippocampal neurons
    Wang, Min
    Bianchi, Riccardo
    Chuang, Shih-Chieh
    Zhao, Wangfa
    Wong, Robert K. S.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 (02) : 411 - 421
  • [40] Group I Metabotropic Glutamate Receptor Interacting Proteins: Fine-Tuning Receptor Functions in Health and Disease
    Kalinowska, Magdalena
    Francesconi, Anna
    CURRENT NEUROPHARMACOLOGY, 2016, 14 (05) : 494 - 503